Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Kidney Dysfunction After Vascularized Composite Allotransplantation

N. Krezdorn, S. Tasigiorgos, L. Wo, R. Lopdrup, M. Turk, H. Kiwanuka, S. Ahmed, P. Petruzzo, E. Bueno, B. Pomahac, LV. Riella,

. 2018 ; 4 (7) : e362. [pub] 20180601

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18028942

Background: Kidney dysfunction is a major complication after nonrenal solid organ transplants. Transplantation of vascularized composite allografts (VCA) has yielded successful midterm outcomes despite high rates of acute rejection and greater requirements of immunosuppression. Whether this translates in higher risks of kidney complications is unknown. Methods: Ninety-nine recipients of facial or extremity transplants from the Brigham and Women's Hospital (BWH) and the International Registry on Hand and Composite Tissue Transplantation (IR) were reviewed. We assessed immunosuppression, markers of renal function over time, as well as pretransplant and posttransplant renal risk factors. Results: Data were obtained from 10 patients from BWH (age at transplant, 42.5 ± 13.8 years) and 89 patients (37.8 ± 11.5 years) from IR. A significant rise in creatinine levels (BWH, P = 0.0195; IR, P < 0.0001) and drop in estimated glomerular filtration rate (GFR) within the first year posttransplant was observed. The BWH and IR patients lost a mean of 22 mL/min GFR and 60 mL/min estimated GFR in the first year, respectively. This decrease occurred mostly in the first 6 months posttransplant (BWH). Pretransplant creatinine levels were not restored in either cohort. A mixed linear model identified multiple variables correlating with renal dysfunction, particularly tacrolimus trough levels. Conclusions: Kidney dysfunction represents a major complication posttransplantation in VCA recipients early on. Strategies to mitigate this complication, such as reducing calcineurin inhibitor trough levels or using alternative immunosuppressive agents, may improve long-term patient outcomes. Standardizing laboratory and data collection of kidney parameters and risk factors in VCA patients will be critical for better understanding of this complication.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18028942
003      
CZ-PrNML
005      
20180821144645.0
007      
ta
008      
180820s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TXD.0000000000000795 $2 doi
035    __
$a (PubMed)30046652
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Krezdorn, Nicco $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Department of Plastic, Aesthetic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
245    10
$a Kidney Dysfunction After Vascularized Composite Allotransplantation / $c N. Krezdorn, S. Tasigiorgos, L. Wo, R. Lopdrup, M. Turk, H. Kiwanuka, S. Ahmed, P. Petruzzo, E. Bueno, B. Pomahac, LV. Riella,
520    9_
$a Background: Kidney dysfunction is a major complication after nonrenal solid organ transplants. Transplantation of vascularized composite allografts (VCA) has yielded successful midterm outcomes despite high rates of acute rejection and greater requirements of immunosuppression. Whether this translates in higher risks of kidney complications is unknown. Methods: Ninety-nine recipients of facial or extremity transplants from the Brigham and Women's Hospital (BWH) and the International Registry on Hand and Composite Tissue Transplantation (IR) were reviewed. We assessed immunosuppression, markers of renal function over time, as well as pretransplant and posttransplant renal risk factors. Results: Data were obtained from 10 patients from BWH (age at transplant, 42.5 ± 13.8 years) and 89 patients (37.8 ± 11.5 years) from IR. A significant rise in creatinine levels (BWH, P = 0.0195; IR, P < 0.0001) and drop in estimated glomerular filtration rate (GFR) within the first year posttransplant was observed. The BWH and IR patients lost a mean of 22 mL/min GFR and 60 mL/min estimated GFR in the first year, respectively. This decrease occurred mostly in the first 6 months posttransplant (BWH). Pretransplant creatinine levels were not restored in either cohort. A mixed linear model identified multiple variables correlating with renal dysfunction, particularly tacrolimus trough levels. Conclusions: Kidney dysfunction represents a major complication posttransplantation in VCA recipients early on. Strategies to mitigate this complication, such as reducing calcineurin inhibitor trough levels or using alternative immunosuppressive agents, may improve long-term patient outcomes. Standardizing laboratory and data collection of kidney parameters and risk factors in VCA patients will be critical for better understanding of this complication.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tasigiorgos, Sotirios $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Wo, Luccie $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Lopdrup, Rachel $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Turk, Marvee $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Kiwanuka, Harriet $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Ahmed, Salman $u Transplantation Research Center, Renal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Petruzzo, Palmina $u Department of Transplantation, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France. Department of Surgery, University of Cagliari, Cagliari, Italy.
700    1_
$a Bueno, Ericka $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Pomahač, Bohdan, $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. $d 1971- $7 xx0117402
700    1_
$a Riella, Leonardo V $u Transplantation Research Center, Renal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA.
773    0_
$w MED00195744 $t Transplantation direct $x 2373-8731 $g Roč. 4, č. 7 (2018), s. e362
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30046652 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180820 $b ABA008
991    __
$a 20180821145026 $b ABA008
999    __
$a ind $b bmc $g 1327593 $s 1025898
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 4 $c 7 $d e362 $e 20180601 $i 2373-8731 $m Transplantation direct $n Transplant Direct $x MED00195744
LZP    __
$a Pubmed-20180820

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...